Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
MTE 16 - Technical Issues after Neoadjuvant Chemoradiation - Surgeon's Perspective (Sign Up Required)
- 07:00 - 08:00
- 10/17/2017
- Location: Room 311 + 312
- Type: Meet the Expert
- Track: Surgery
-
+
MTE 16.01 - Difficulties of Surgery After Induction of Chemoradiotherapy
07:00 - 07:30 | Presenter: Eric Vallieres
- Abstract
Loading... -
+
MTE 16.02 - Surgery for Stage IIIA NSCLC - Surgeon's Perspective
07:30 - 08:00 | Presenter: Gail Elizabeth Darling
- Abstract
Loading...
-
+
MTE 17 - Neuroendocrine Tumor (Sign Up Required)
- 07:00 - 08:00
- 10/17/2017
- Location: Room 418
- Type: Meet the Expert
- Track: SCLC/Neuroendocrine Tumors
-
+
MTE 17.01 - Pathological Features of Neuroendocrine Tumors
07:00 - 07:30 | Presenter: Yuichi Ishikawa
- Abstract
Loading... -
+
MTE 17.02 - Surgical Strategy for the Treatment of Neuroendocrine Tumors
07:30 - 08:00 | Presenter: Enrico Ruffini | Author(s): Pier Luigi Filosso, P. Lyberis, A. Oliaro
- Abstract
Loading...
-
+
MTE 18 - Treatment for Squamous Cell Carcinoma (Sign Up Required)
- 07:00 - 08:00
- 10/17/2017
- Location: Room 313 + 314
- Type: Meet the Expert
- Track: Advanced NSCLC
-
+
MTE 18.01 - Treatment for Squamous Cell Carcinoma
07:00 - 08:00 | Presenter: Paul K. Paik
- Abstract
Loading...
-
+
MTE 19 - Laser Therapy for Early Stage and Airway Obstruction (Sign Up Required)
- 07:00 - 08:00
- 10/17/2017
- Location: Room 317
- Type: Meet the Expert
- Track: Pulmonology/Endoscopy
-
+
MTE 19.01 - Laser Therapy for Airway Obstruction
07:00 - 07:30 | Presenter: Kenneth Kazuto Sakata
- Abstract
Loading... -
+
MTE 19.02 - Ablative Therapy for Early Stage Lung Cancer
07:30 - 08:00 | Presenter: Antoni Rosell
- Abstract
Loading...
-
+
MTE 20 - Liquid Biopsy (Sign Up Required)
- 07:00 - 08:00
- 10/17/2017
- Location: Room 303 + 304
- Type: Meet the Expert
- Track: Biology/Pathology
-
+
MTE 20.01 - Recent Advances in Liquid Biopsy
07:00 - 07:30 | Presenter: Daniel SW Tan
- Abstract
No abstract available for this presentation
-
+
MTE 20.02 - Recent Advances in Liquid Biopsy
07:30 - 08:00 | Presenter: Geoffrey R. Oxnard
- Abstract
Loading...
-
+
MTE 21 - Search for Novel Driver Mutations (Sign Up Required)
- 07:00 - 08:00
- 10/17/2017
- Location: Room 315
- Type: Meet the Expert
- Track: Chemotherapy/Targeted Therapy
-
+
MTE 21.01 - Novel Driver Mutations for Lung Cancer
07:00 - 07:30 | Presenter: Koichi Goto
- Abstract
No abstract available for this presentation
-
+
MTE 21.02 - New Molecular Diagnosis Platforms for Clinicians
07:30 - 08:00 | Presenter: Marc Ladanyi
- Abstract
No abstract available for this presentation
-
+
SH 01 - WCLC 2017 Highlights of the Previous Day
- 07:00 - 08:00
- 10/17/2017
- Location: Room 502
- Type: Scientific Highlights
- Track: Advanced NSCLC
-
+
SH 01.01 - Advanced NSCLC, Clinical Design, Statistics and Clinical Trials, Immunology and Immunotherapy and Patient Advocacy
07:00 - 07:20 | Presenter: Suresh S Ramalingam
- Abstract
No abstract available for this presentation
-
+
SH 01.02 - Surgery
07:20 - 07:40 | Presenter: Masafumi Kawamura
- Abstract
No abstract available for this presentation
-
+
SH 01.03 - Biology/Pathology and Epidemiology/Primary Prevention/Tobacco Control and Cessation
07:40 - 08:00 | Presenter: Y. Takiguchi
- Abstract
No abstract available for this presentation
-
+
SH 02 - WCLC 2017 Highlights of the Previous Day
- 07:00 - 08:00
- 10/17/2017
- Location: Room 503
- Type: Scientific Highlights
- Track: Biology/Pathology
-
+
SH 02.01 - Chemotherapy/Targeted Therapy and SCLC/Neuroendocrine Tumors
07:00 - 07:20 | Presenter: Robert Pirker
- Abstract
No abstract available for this presentation
-
+
SH 02.02 - Radiotherapy
07:20 - 07:40 | Presenter: Sung-Ja Ahn
- Abstract
No abstract available for this presentation
-
+
SH 02.03 - Biology/Pathology, Mesothelioma and Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
07:40 - 08:00 | Presenter: Yuko Minami
- Abstract
No abstract available for this presentation
-
+
PL 02 - Presidential Symposium including Top 3 Abstracts and James Cox Lectureship Award Presentation
- 08:15 - 09:45
- 10/17/2017
- Location: Plenary Hall (Exhibit Hall D)
- Type: Plenary Session
- Track: Early Stage NSCLC
- Moderators:Hisao Asamura, Keunchil Park
-
+
PL 02.01 - Introduction and Welcome
08:15 - 08:20
- Abstract
No abstract available for this presentation
-
+
PL 02.02 - Patient-Reported Outcomes with Durvalumab after Chemoradiation in Locally Advanced, Unresectable NSCLC: Data from PACIFIC
08:20 - 08:30 | Presenter: R. Hui | Author(s): M. Özgüroğlu, D. Daniel, D.V. Baz, S. Murakami, T. Yokoi, A. Chiappori, K.H. Lee, M. De Wit, B. Chul Cho, J.E. Gray, A. Rydén, L. Viviers, L. Poole, P.A. Dennis, S.J. Antonia
- Abstract
Loading... -
+
PL 02.03 - Discussant - PL 02.02
08:30 - 08:40 | Presenter: Michael Boyer
- Abstract
No abstract available for this presentation
-
+
PL 02.04 - SCAT Ph III Trial: Adjuvant CT Based on BRCA1 Levels in NSCLC N+ Resected Patients. Final Survival Results a Spanish Lung Cancer Group Trial
08:40 - 08:50 | Presenter: Bartomeu Massuti | Author(s): Manuel Cobo Dols, M. Rodriguez-Paniagua, I. Ballesteros, T. Morán, R. Arrabal, J.L. González-Larriba, I. Barneto, Y.W. Pun, J. De Castro, S. Ponce Aix, C. Baamonde, M.A. Muñoz, G. López-Vivanco, J.J. Rivas De Andrés, D. Isla, R. López, José Miguel Sánchez-Torres, J. Sánchez Paya, Rafael Rosell
- Abstract
Loading... -
+
PL 02.05 - Discussant - PL 02.04
08:50 - 09:00 | Presenter: Joan Schiller
- Abstract
No abstract available for this presentation
-
+
PL 02.06 - The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for R Status Descriptors for Non-Small Cell Lung Cancer
09:00 - 09:10 | Presenter: John G Edwards | Author(s): K. Chansky, L. Shemanski, Paul Emile Van Schil, Hisao Asamura, Ramon Rami-Porta
- Abstract
Loading... -
+
PL 02.07 - Discussant - PL 02.06
09:10 - 09:20 | Presenter: Kemp Kernstine
- Abstract
No abstract available for this presentation
-
+
PL 02.08 - James Cox Lectureship Award Presentation
09:20 - 09:45 | Presenter: James D. Cox
- Abstract
No abstract available for this presentation
-
+
P2.01 - Advanced NSCLC
- 09:00 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P2.01-001 - Serum Albumin Level Predicts the Survival Benefit of Chemotherapy in Elderly Advanced NSCLC Patients with Poor Performance Status
09:00 - 09:00 | Presenter: Satoshi Ikeda | Author(s): H. Yoshioka, S. Ikeo, M. Morita, N. Sone, T. Niwa, A. Nishiyama, T. Yokoyama, A. Sekine, T. Ogura, T. Ishida
- Abstract
Loading... -
+
P2.01-002 - Survival of Patients with Advanced Non-Small Cell Lung Cancer at Single Institute in Eastern Thailand, 2013-2016
09:00 - 09:00 | Presenter: Sitthi Sukauichai | Author(s): C. Tovanabutra, K. Chomprasert, S. Wanglikitkoon
- Abstract
Loading... -
+
P2.01-003 - Does Astragalus Membranaceus Root Extract Have Any Survival Benefit for Metastatic Non-Small Cell Lung Cancer?
09:00 - 09:00 | Presenter: Adnan Aydiner | Author(s): R. Ciftci
- Abstract
Loading... -
+
P2.01-004 - Safety and Efficacy of Nab-Paclitaxel plus Carboplatin in Elderly Patients with NSCLC (ABOUND.70+)
09:00 - 09:00 | Presenter: Corey J Langer | Author(s): E.C. Anderson, R.M. Jotte, Jonathan W. Goldman, D.E. Haggstrom, D.A. Smith, C.S.R. Dakhil, K. Konduri, E. Kim, T.J. Ong, A. Sanford, K.I. Amiri, J. Weiss
- Abstract
Loading... -
+
P2.01-005 - A Randomized Phase II Trial of Erlotinib vs S-1 in Patients with NSCLC as Third- or Fourth-Line Therapy (HOT1002)
09:00 - 09:00 | Presenter: Yasutaka Kawai | Author(s): H. Asahina, Y. Ikezawa, S. Oizumi, T. Ogi, M. Watanabe, T. Amano, H. Dosaka-Akita, H. Isobe, M. Nishimura
- Abstract
Loading... -
+
P2.01-006 - Effect of Maintenance Using Pemetrexed with and without Bevacizumad in Patients Advanced Lung Cancer in Non-Small Cells
09:00 - 09:00 | Presenter: Mayra Galeana Hernandez | Author(s): M. Magallanes Maciel
- Abstract
Loading... -
+
P2.01-007 - Molecular Characterization of Non-Small Cell Lung Cancers (NSCLC) in Young Patients from an Argentine Population
09:00 - 09:00 | Presenter: Valeria Cecilia Denninghoff | Author(s): G.J. Recondo, M.T. Cuello, M.M. García Falcone, V. Romano, M. Greco, V. Wainsztein, F. Galanternik, M. De La Vega, E. Rojas Bilbao, M.A. Avagnina, G. Recondo
- Abstract
Loading... -
+
P2.01-008 - Combination of Bavacizumab with Conventional Chemotherapy Shows Better Prognosis in Patients with Lung Cancer with Liver Metastasis
09:00 - 09:00 | Presenter: Kim Ki-Up | Author(s): C. Sung Jun, K. So-Mye
- Abstract
Loading... -
+
P2.01-009 - The Efficacy of Bevacizumab Adding in Standard First Line Chemotherapy and Maintenance Treatment in Advanced NSCLC: A Network Meta-Analysis
09:00 - 09:00 | Presenter: Voralak Vichapat | Author(s): Thanyanan Reungwetwattana, A. Thakkinstian
- Abstract
Loading... -
+
P2.01-010 - Risk Score for Predicting Acute Exacerbation after Chemotherapy in Lung Cancer Associated with Interstitial Pneumonia
09:00 - 09:00 | Presenter: Kazutoshi Isobe | Author(s): K. Kaburaki, Hiroshi Kobayashi, G. Sano, K. Sugino, S. Sakamoto, Y. Takai, Takashi Makino, N. Tochigi, Akira Iyoda, S. Homma
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.01-012 - Impact of Brain Metastases on the Humanistic Burden Incurred by Patients with Advanced Non-small Cell Lung Cancer (A-nsclc)
09:00 - 09:00 | Presenter: Oana Chirita | Author(s): G. Taylor-Stokes, R. Wood, M. Lees
- Abstract
Loading... -
+
P2.01-013 - Nab-Paclitaxel/Carboplatin in Elderly Patients with NSCLC (ABOUND.70+): Analysis of Safety and Quality of Life (QoL) by Cycle
09:00 - 09:00 | Presenter: Corey J Langer | Author(s): E. Kim, J. Weiss, E.C. Anderson, R.M. Jotte, Jonathan W. Goldman, D.E. Haggstrom, D.A. Smith, C.S.R. Dakhil, K. Konduri, T. Berry, T.J. Ong, A. Sanford, K.I. Amiri
- Abstract
Loading... -
+
P2.01-014 - ABOUND.PS2: Safety and Efficacy of Nab-Paclitaxel–Based Therapy in Patients with NSCLC and ECOG PS 2
09:00 - 09:00 | Presenter: Ajeet Gajra | Author(s): N. Abdel Karim, D.A. Mulford, M.R. Matrana, H.Y. Ali, Edgardo S. Santos, T.J. Ong, A. Sanford, K.I. Amiri, David R Spigel
- Abstract
Loading... -
+
P2.01-015 - Longitudinal Assessment of Performance Status (PS) in Patients with NSCLC and ECOG PS 2 on Nab-Paclitaxel–Based Therapy
09:00 - 09:00 | Presenter: Nagla Abdel Karim | Author(s): D.A. Mulford, M.R. Matrana, H.Y. Ali, Edgardo S. Santos, T.J. Ong, A. Sanford, K.I. Amiri, David R Spigel, Ajeet Gajra
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.01-018 - Risk Factors in Patients with Pathological N1 or N2 Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Yoshimasa Tokunaga | Author(s): T. Okamoto, Y. Kita
- Abstract
Loading... -
+
P2.01-019 - The Necessity of Contrast-enhanced CT before CT-Guided Percutaneous Transthoracic Needle Biopsy for Lung Lesions
09:00 - 09:00 | Presenter: Tang Feng Lv | Author(s): H. Hu, H. Liu, Yong Song
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.01-021 - Efficacy of Single-Agent Chemotherapy after Exposure to Nivolumab in Advanced Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Yuto Yasuda | Author(s): Tomoko Funazo, T. Nomizo, T. Tsuji, Hironori Yoshida, Yuichi Sakamori, H. Nagai, H. Ozasa, T. Hirai, Y.H. Kim
- Abstract
Loading... -
+
P2.01-022 - Nintedanib/Docetaxel Efficacy in Advanced Lung Adenocarcinoma Treated with 1L Chemotherapy/2L Immunotherapy in Nintedanib NPU
09:00 - 09:00 | Presenter: Jesus Corral | Author(s): Margarita Majem, D. Rodríguez-Abreu, Enric Carcereny, Angel Artal Cortes, M. Llorente, J.M. López Picazo, Y. García, M. Domine, M.P. Lopez Criado
- Abstract
Loading... -
+
P2.01-023 - Reasons for Withholding Systemic Therapy in Stage IV NSCLC: Comparison of Years 2004 to 2007 and 2010 to 2013
09:00 - 09:00 | Presenter: Gouri Shankar Bhattacharyya | Author(s): H. Malhotra, K. Govindbabu, G. Biswas, A. Vora, T. Shahid
- Abstract
Loading... -
+
P2.01-024 - Prognostic Value of Body Fat Mass Ratio in Lung Cancer Patients
09:00 - 09:00 | Presenter: Abdurrahman ?sikdogan | Author(s): N. Akdeniz, A. Akbay, Z. Oruc, M.A. Kaplan
- Abstract
Loading... -
+
P2.01-025 - Evaluation of Calculating Carboplatin Dosage in Carboplatin–Pemetrexed Therapy in Chinese Patients with Advanced NSCLC
09:00 - 09:00 | Presenter: Yixiang Zhu | Author(s): P. Xing, J. Li
- Abstract
Loading... -
+
P2.01-026 - Distribution of Metastatic Disease in Survival Outliers with Stage IV Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: D. Gwyn Bebb | Author(s): A. Fung, A. D'Silva, H. Li, S. Otsuka
- Abstract
Loading... -
+
P2.01-027 - Clinical Significance of Topoisomerase-II Expression in Patients with Non-Small Cell Lung Cancer Treated with Amrubicin
09:00 - 09:00 | Presenter: Reiko Sakurai | Author(s): K. Kaira, Yosuke Miura, Y. Tomizawa, Y. Tsukagoshi, T. Masuda, Norimitsu Kasahara, N. Sunaga, R. Saito, T. Hisada
- Abstract
Loading... -
+
P2.01-028 - Clinical Correlation between CTCs Enumeration Based on New Detection Method and Chemotherapy Efficacy in Human Advanced Lung Cancer
09:00 - 09:00 | Presenter: Honglei Chen | Author(s): H. Chen, C. Zhao
- Abstract
Loading... -
+
P2.01-029 - Real World Report of Clinical Outcomes of Bevacizumab in First-Line or Later-Line Treatment for Patients with Advanced NSCLC
09:00 - 09:00 | Presenter: Yalei Wang | Author(s): X. Hao, Yixiang Zhu, X. Hu, H. Wang, Y. Liu, Yuxin Mu, Junling Li, Y. Wen, Y. Wang
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.01-031 - Use of Geriatric Assessment (GA) in Clinical Practice for Stage IV Non-Small Cell Lung Cancer (NSCLC). The GIDO Experience
09:00 - 09:00 | Presenter: Regina Gironés | Author(s): F. Aparisi, A. Sánchez, J. García, Ó. Juan
- Abstract
Loading... -
+
P2.01-032 - A Randomized Phase Ii Trial of Selumetinib + Platinum-pemetrexed (Pem-c) in Kras Wildtype (Wt)/Unknown NSCLC: CCTG Ind219
09:00 - 09:00 | Presenter: Barbara Melosky | Author(s): Penelope Bradbury, D. Tu, G. Nicholas, P. Wheatley-Price, S.A. Laurie, Glenwood Goss, M. Florescu, N. Basappa, A. Reiman, A. Tan, Desiree Hao, J. Rotherstein, Natasha B Leighl, John R Goffin, C. Kollmannsberger, P. Kaurah, P. Brown-Walker, L. Seymour
- Abstract
Loading... -
+
P2.01-033 - Leptomeningeal Metastasis from Non-Small Cell Lung Cancer: A Single Center Experience in Chinese Patients
09:00 - 09:00 | Presenter: Junling Li | Author(s): X. Wu, L. Yu, Y.B. Yang
- Abstract
Loading... -
+
P2.01-034 - Phase I/II Trial of Weekly Nab-Paclitaxel as 2nd or 3rd Line Treatment in NSCLC Without Driver Mutations. (OLCSG1303)
09:00 - 09:00 | Presenter: Kenichiro Kudo | Author(s): Shoichi Kuyama, Daijiro Harada, T. Kozuki, A. Bessho, K. Hotta, H. Yoshioka, K. Gemba, N. Takigawa, I. Oze, K. Kiura
- Abstract
Loading... -
+
P2.01-035 - Phase II Study: Weekly Docetaxel as First Line Chemotherapy for Elderly Patients with Squamous-Cell Non-Small-Cell Lung Cancer
09:00 - 09:00 | Presenter: Kyung Ho Kang | Author(s): Sung Yong Lee, J.H. Choi, S.M. Chung, J.Y. Oh, Y.S. Lee, K.H. Min, G.Y. Hur, J.J. Shim, H.K. Lee
- Abstract
Loading... -
+
P2.01-036 - Symptom Trajectories During Chemotherapy Predict Overall Survival in Patients with Advanced Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Qiuling Shi | Author(s): X.S. Wang, L.A. Williams, T.R. Mendoza, George R. Simon, C.S. Cleeland
- Abstract
Loading... -
+
P2.01-037 - Clinical Impact of Interstitial Lung Disease on Advanced Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Hajime Oi | Author(s): H. Taniguchi, Y. Kondoh, Tomoki Kimura, K. Kataoka, T. Matsuda, T. Yokoyama
- Abstract
Loading... -
+
P2.01-038 - Determinants of Frailty and Treatment Toxicity in Non-Small Cell Lung Cancer Patient
09:00 - 09:00 | Presenter: Marie-Eve Boucher | Author(s): Laura Mezquita, E. Auclin, M. Mons, J. Marghadi, M. Charrier, Roberto Ferrara, David Planchard, G. Anas, Cecile Le Pechoux, Angela Botticella, C. Caramella, J. Adam, J. Soria, Benjamin Besse
- Abstract
Loading... -
+
P2.01-039 - Erythropoiesis-Stimulating Agents for Chemotherapy-Induced Anaemia in Lung Cancer: Efficacy, Toxicity and Effect on Survival
09:00 - 09:00 | Presenter: Kostas Syrigos | Author(s): V. Xirou, I. Gkiozos, D. Grapsa, Ioannis Dimitroulis
- Abstract
Loading... -
+
P2.01-040 - Pemetrexed plus Platinum Chemotherapy with or Without Immunotherapy in Non-Squamous NSCLC: Descriptive Safety Analysis
09:00 - 09:00 | Presenter: Vassiliki A Papadimitrakopoulou | Author(s): Ramaswamy Govindan, Hossein Borghaei, S. He, J.S. Kim
- Abstract
Loading... -
+
P2.01-041 - Pemetrexed plus Platinum Chemotherapy with or Without ImmunoResponses of Bevacizumab plus Cisplatin for the Non-Squamous Non-Small-Cell Lung Cancer Patients with Malignant Pleural Effusionstherapy in Non-Squamous NSCLC: Descriptive Safety Analysis
- Abstract
Loading... -
+
P2.01-042 - Perioperative Chemotherapy with Pemetrexed and Cisplatin for Pulmonary LCNEC: A Case Report and Literature Review
09:00 - 09:00 | Presenter: Hong Tang
- Abstract
Loading... -
+
P2.01-043 - PD-L1 Expression, EGFR and KRAS Mutations in First-Line Therapy (1L) for Non-Small Cell Lung Cancer (NSCLC) Patients
09:00 - 09:00 | Presenter: James Rigas | Author(s): D. Cronin-Fenton, T. Dalvi, E. Hedgeman, M. Norgaard, L. Petersen, H. Hansen, J. Fryzek, D. Lawrence, J. Walker, A. Mellemgaard, T. Rasmussen, N. Shire, D. Potter, S. Hamilton-Dutoit, H. Sorensen
- Abstract
Loading... -
+
P2.01-044 - The Correlation Between One Year Survival and the Affecting Factors of Lung Cancer Patients at Dr. Moewardi Hospital Surakarta
09:00 - 09:00 | Presenter: Ana Rima | Author(s): H.N. Mayasari, S. Sunarso, Y.S. Sutanto
- Abstract
Loading... -
+
P2.01-045 - The Efficiency of Apatinib plus S-1 as Laterline Chemotherapy for Advanced Non-Small-Cell Lung Cancer
09:00 - 09:00 | Presenter: Zhiyong Wu | Author(s): G. Dai, J. Wu, Y. Wang
- Abstract
Loading... -
+
P2.01-046 - Clinical Characteristics of Survival with De Novo Versus Relapsed Metastatic Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Gwyn Bebb | Author(s): A.J.W. Gibson, H. Li, A. D'Silva, R.A. Tudor, A.A. Elegbede, S. Otsuka, W. Cheung
- Abstract
Loading... -
+
P2.01-047 - A Phase 1 Trial of Dose Escalated BGB324 in Combination with Docetaxel for Previously Treated Advanced NSCLC
09:00 - 09:00 | Presenter: David E Gerber | Author(s): P. Levin, F. Fattah, R.A. Brekken, P. Currykosky, J. Padro, M. Yule, K. Wnuk-Lipinska, E.M. Nævdal, A. Boniecka, G. Gausdal, J. Lorens
- Abstract
Loading... -
+
P2.01-048 - Early Changes in Body Composition in Metastatic Non-Small Cell Lung Cancer (NSCLC) Are Predictive for Poor Overall Survival
09:00 - 09:00 | Presenter: Anne-Marie C. Dingemans | Author(s): J.H.R.J. Degens, K.J.C. Sanders, E.E.C. De Jong, A.M.W.J. Schols
- Abstract
Loading... -
+
P2.01-049 - Long Progression Free Survival and Overall Survival in Advanced NSCLC Patients with EGFR Mutation and Complete Response with TKI Treatment
09:00 - 09:00 | Presenter: Omar Macedo-Pérez | Author(s): I. Lyra-González, D.B. Marroquín-Flores, G. Cruz-Rico, L.A. Ramírez-Tirado, L. Valdez-Rojas, A. Tabares-Nañez, J.E. Gonzales-Nogales, Oscar Arrieta
- Abstract
Loading... -
+
P2.01-050 - Predicting Risk of Hospitalization in Patients with NSCLC Receiving Chemotherapy Using the LCSS 3-Item Global Index (3-IGI)
09:00 - 09:00 | Presenter: Richard J Gralla | Author(s): Patricia J. Hollen, N. Gaspe, R. Hall, R. Genzler, H. Cordero, Haiying Cheng, J. Gildersleeve, Jeffrey Crawford, L. Rosen, M. Lesser
- Abstract
Loading... -
+
P2.01-051 - Randomized Study of Pemetrexed Versus Erlotinib as Maintenance Therapy in Metastatic /Locally Advanced EGFR Mutation Negative NSCLC
09:00 - 09:00 | Presenter: Vikas Talreja | Author(s): A. Joshi, V. Noronha, V. Patil, M. Sharma, C. Vora, S. Goud, S. More, S. Shah, A. Mahajan, A. Janu, R. Kaushal, K. Prabhash
- Abstract
Loading... -
+
P2.01-052 - Does Radiomics Improves the Survival Prediction in Non Small Cell Lung Cancer?
09:00 - 09:00 | Presenter: Ravindra Patil | Author(s): G. M, L. Wee, A. Dekker
- Abstract
Loading... -
+
P2.01-053 - Outcome of Clinical Management of Elderly and Younger Patients with NSCLC Inside a Private Institution (Oncosalud-AUNA)
09:00 - 09:00 | Presenter: Jose Maria Gutierrez Castañeda | Author(s): Claudio Flores, R. Ruiz Mendoza, L.A. Mas Lopez, A. Aguilar, C. Vallejos, L. Pinillos-Ashton
- Abstract
Loading... -
+
P2.01-054 - Inclusion of Central Nervous System Metastasis in Lung Cancer Early Phase Clinical Trials
09:00 - 09:00 | Presenter: Narjust Duma | Author(s): M. Gonzalez Velez, V. Mariotti, R. Carr, Erin Schenk, K. Leventakos, J. Molina, Aaron S. Mansfield, Alex Adjei
- Abstract
Loading... -
+
P2.01-055 - Examining Metabolomics as a Prognostic Marker in Metastatic Non–Small Cell Lung Cancer Patients Undergoing First-Line Chemotherapy
09:00 - 09:00 | Presenter: Desiree Hao | Author(s): A. Sengupta, K. Ding, Natasha B Leighl, Frances A Shepherd, L. Seymour, A. Weljie
- Abstract
Loading... -
+
P2.01-056 - Use of Cell-Free Circulating RNA (cfRNA) Expression of PD-L1 and ERCC1 in Plasma to Monitor Response to Therapy in NSCLC
09:00 - 09:00 | Presenter: Luis E Raez | Author(s): K. Danenberg, A.B. Castrellon, S. Rabizadeh, J. Usher, Y. Jaimes, B. Hunis, Martin Frederik Dietrich, C. Habaue, P. Danenberg
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.01-058a - Dose Serum Lactate Dehydrogenase Have a Significant Prognostic Value in Lung Cancer?
09:00 - 09:00 | Presenter: Sharareh Seifi | Author(s): A. Khosravi, Z. Esfahani-Monfared, B. Salimi
- Abstract
No abstract available for this presentation
-
+
P2.01-059 - Breast Metastasis from Pulmonary Cancer: A Case Report. University Hospital "Shefqet Ndroqi" Tirana Albania 2008
09:00 - 09:00 | Presenter: Fadil Gradica | Author(s): D. Argjiri, L. Lisha, I. Avdiu, G. Cerga, A. Lala, F. Kokici, A. Cani, A. Kalenja, L. Zhegu
- Abstract
Loading... -
+
P2.01-060 - Outcomes Following Gamma Knife Radiosurgery in Patients with Non-Small Cell Lung Cancer with Brain Metastases
09:00 - 09:00 | Presenter: Oliver Coen | Author(s): S. El Badri, P. Hatfield, K.N. Franks, P. Jain, M. Snee, Katy Louise Clarke
- Abstract
Loading... -
+
P2.01-061 - Mode of Lung and Airway Metastasis of NSCLC: Review of Chest CT Findings
09:00 - 09:00 | Presenter: Mi Young Kim | Author(s): Jae Cheol Lee, H.R. Kim, H.J. Koo
- Abstract
Loading... -
+
P2.01-062 - Primary Lung Adenocarcinoma in the Young with Multiple Metastases: An Autopsy Report of 2 Cases
09:00 - 09:00 | Presenter: Randell Santos Arias | Author(s): F.S. Templo, Jr., L.C. Subia, O.P.R. Balisan
- Abstract
Loading... -
+
P2.01-063 - Outcomes of Patients with Oligometastatic Non-Small Cell Lung Cancer Who Were Treated with Radical Treatment
09:00 - 09:00 | Presenter: Ahmet Bilici | Author(s): F. Selcukbiricik, R. Rzazade, O.F. Olmez, H.B. Caglar, O. Yildiz
- Abstract
Loading... -
+
P2.01-064 - Co-Existing Mutations and Their Clinical Implications in Non-Small Cell Lung Cancer: Korean Lung Cancer Consortium (KLCC-13-01)
09:00 - 09:00 | Presenter: Bo Mi Ku | Author(s): N.L. Lee, M.S. Kim, Jong-Mu Sun, S. Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
- Abstract
Loading... -
+
P2.01-065 - Clinico-Radiological and Pathological Evaluation of Lung Adenocarcinoma with Infiltration on the Computed Tomography of the Chest
09:00 - 09:00 | Presenter: Asuka Okada | Author(s): S. Choh, T. Nakai, C. Ohbayashi, Y. Kurono, M. Ueda, K. Katayama, N. Koguchi, S. Murakami, H. Takenaka
- Abstract
Loading... -
+
P2.01-066 - Targeted Therapy for Lung Cancer: Liquid Biopsy or Tumor Sampling? A Case-Control Study
09:00 - 09:00 | Presenter: Zhen-Yu Ding | Author(s): C. Wang
- Abstract
Loading... -
+
P2.01-067 - Treatment of the Patients with Oncological Emergencies with Massive Pleural Effusion at the First Hospital Visit
09:00 - 09:00 | Presenter: Kazuhiro Ito | Author(s): Junichi Shimada, D. Kato, M. Inoue
- Abstract
Loading... -
+
P2.01-068 - Lobectomy Improve the Survival of Non-Small Cell Lung Cancer Patients with Occult Malignant Pleural Disease First Detected at Thoracotomy
09:00 - 09:00 | Presenter: Shaolei Li | Author(s): S. Zhang, Miao Huang, Y. Ma, Y. Yang
- Abstract
Loading... -
+
P2.01-069 - Radiologists' Considerations to Determine the Origin of Tumor on Chest CT: Lung vs Mediastinum
09:00 - 09:00 | Presenter: Junghwa Choi | Author(s): S. Song
- Abstract
Loading... -
+
P2.01-070 - FAACT- Anorexia Cachexia Scale: Cut-Off Value for the Anorexia Diagnosis in NSCLC Patients
09:00 - 09:00 | Presenter: Jenny Turcott | Author(s): L. Ramirez-Tirado, L.F. Oñate-Ocaña, D. Flores-Estrada, Z.L. Zatarain-Barron, G. Soca-Chafre, Oscar Arrieta
- Abstract
Loading... -
+
P2.01-071 - Efficacy of Thoracic Radiotherapy in Oligometastatic Non-Small-Cell Lung Cancer Harboring Wild-Type EGFR After First-Line Chemotherapy
09:00 - 09:00 | Presenter: Congying Xie | Author(s): B. Lin, Xiance Jin
- Abstract
Loading... -
+
P2.01-072 - Local Management of Oligometastasis in Non-Small Cell Lung Cancer (NSCLC)
09:00 - 09:00 | Presenter: Margarita Majem Tarruella | Author(s): M. Riudavets Melia, L.P. Del Carpio Huerta, A. Barba Joaquín, G. Anguera Palacios, I.G. Sullivan, A. Callejo Perez, N. Farré, A. Torrego, V. Pajares, E. Martínez, J.C. Trujillo, C. De Quinana
- Abstract
Loading... -
+
P2.01-073 - Prognostic Factors Analysis of Non-Small Cell Lung Cancer with Brain Metastases
09:00 - 09:00 | Presenter: Jiancheng Li | Author(s): Y. Xue
- Abstract
Loading... -
+
P2.01-074 - Wait and See: A Favorable Alternative for R-M1a and S-M1a NSCLC Patients
09:00 - 09:00 | Presenter: Ying Chen
- Abstract
Loading... -
+
P2.01-075 - Genomic Changes and Clinical Characteristics Associated with Wood-Smoke Exposure in Patients with Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Norma Yanet Hernandez-Pedro | Author(s): G. Soca-Chafre, C. Alaez, K. Carrillo-Sanchez, P. Barrios-Bernal, Oscar Arrieta
- Abstract
Loading... -
+
- Abstract
No abstract available for this presentation
-
+
P2.01-075b - Analysis of the Safety and Usefulness of Nab-Paclitaxel Therapy in Patients with Non-Small Cell Carcinoma
09:00 - 09:00 | Presenter: I. Eriko
- Abstract
Loading... -
+
P2.01-075c - FGFR1 as an Intrinsic Resistance Mechanism in Erlotinib Treated EGFR Mutated NSCLC
09:00 - 09:00 | Presenter: Kristine Raaby Jakobsen | Author(s): J. Vad-Nielsen, S. Weiss, M.S. Clement, T.F. Daugaard, B.S. Soerensen, A.L. Nielsen
- Abstract
Loading... -
+
P2.01-075d - Analysis of Early Survival in Patients with Advanced Non-Squamous NSCLC Treated with Nivolumab: The Italian Expanded Access Program Experience
09:00 - 09:00 | Presenter: Hector Josè Soto Parra | Author(s): E. Defraia, D. Pozzessere, A. Bettini, A. Scoppola, A. Pazzola, A. Bertolini, P. Tagliaferri, P.F. Conte, G. Surico, A. Berruti, M. Minelli, A. Santo, E.M. Ruggeri, G. Cartenì, M. Pagano, F. Verderame, F. Roila, A. Del Monte, M. Tiseo
- Abstract
Loading... -
+
P2.01-075e - Neutrophil to Lymphocyte Ratio Predicts Survival in Advanced NSCLC Patients Treated with Second-Line PD-1 Immune Checkpoint Inhibitors
09:00 - 09:00 | Presenter: Philip Bonomi | Author(s): S. Labomascus, I. Fughhi, M.J. Fidler, J.A. Borgia, S. Basu, M. Hoch, M. Batus
- Abstract
No abstract available for this presentation
-
+
P2.01-075f - Detection of EML4-ALK and ROS1 Fusion Gene in NSCLC by PNA-Assisted Real-Time RT-PCR Using Fluorescent Meting Curve Analysis
09:00 - 09:00 | Presenter: Myosun Kim
- Abstract
Loading... -
+
P2.01-075g - Genotyping of EML4-ALK Fusion Gene by PNA-Assisted Real-Time RT-PCR Using Fluorescent Meting Curve Analysis
09:00 - 09:00 | Presenter: Myosun Kim
- Abstract
Loading...